我们对心房瘤的10年经验:并发门干预真的有保证吗?
Ketika Potey1, Narender Jhajhria1, Manish Mallik1
1Department of Cardiothoracic and Vascular Surgery, Dr Ram Manohar Lohia Hospital and Post Graduate Institute of Medical Education and Research, New Delhi, New Delhi, India.
Brazilian journal of cardiovascular surgery
|February 5, 2024
概括
主要心脏肌瘤,罕见的瘤,通常会导致心心膜缺陷. 瘤切除后的手术内评估对于确定必要的门干预至关重要,修复通常会产生最好的结果.
科学领域:
- 心血管外科心血管外科
- 心脏瘤学 心脏瘤学
- 膜心脏疾病 膜心脏疾病
背景情况:
- 初级心脏肌瘤是一种罕见的瘤.
- 膜病变经常伴随神经瘤,原因是环状扩张和阻塞等因素.
- 人们经常认为,手术切除myxoma可以在没有进一步的门干预的情况下解决症状.
研究的目的:
- 为了分析心脏肌瘤切除的结果.
- 评估同时进行门干预的必要性和有效性.
- 评估手术内发现在指导外科决定中的作用.
主要方法:
- 一个10年的回顾性描述性研究.
- 对22名接受心脏肌瘤切除术的患者的分析.
- 评估手术前,手术内和手术后的门形态和结果.
主要成果:
- 六名患者成功地通过环结膜整形手术修复了 mitra 门.
- 在手术前和手术期间, mitrale regurgitation 的情况各不相同,有些病例在切割后发生.
- 一名患者因类风湿性中狭窄症需要进行中膜置换.
结论:
- 心脏肌瘤经常导致心交膜缺陷.
- 在瘤切除后,对 mitra 膜进行手术内评估至关重要.
- 对门干预的量身定制方法,包括通过戒指解环整形进行修复,可提供最佳的外科结果.
相关概念视频
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753